Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMC.L Regulatory News (AMC)

  • There is currently no data for AMC

Fixed Term Loan Note Instrument to Complete TEO

12 Mar 2020 10:48

RNS Number : 9161F
Amur Minerals Corporation
12 March 2020
 

 

12 March 2020

 

AMUR MINERALS CORPORATION

(AIM: AMC)

 

Fixed Term Loan Note Instrument to Complete TEO

 

Amur Minerals Corporation ("Amur" or the "Company"), a nickel-copper sulphide mineral exploration and resource development company focused on its Kun-Manie project in the far east of Russia , is pleased to announce that it has entered yesterday into a fixed term loan note instrument (the "Loan Notes") of up to £1.5 million with Plena Global Opportunities LLC (the "Investor").

 

Highlights:

 

· The Loan Note of up to £1.5 million consists of three advances of Loan Notes with the initial advance of £0.5 million (the "Initial Advance") being withdrawn by the Company and funds expected to be received by 13 March 2020.

 

· A second advance of £0.5 million is available after three months and a final advance of £0.5 million is available after six months by mutual consent.

 

· Each tranche of Loan Notes is repayable by the Company in three months of the advance being made. Any of the relevant tranches of Loan Notes are not repaid at that date, the term of the Loan Notes shall automatically be extended by a further period of 12 months.

 

· When Loan Notes are redeemed the Company shall pay the noteholder in cash an amount equal to 105 per cent of the principal amount of the Loan Notes plus interest equal to 10 per cent of the principal amount being so redeemed.

 

· If the Company elects not to repay the advance by the three month repayment date the Investor can elect to convert that outstanding advance at any time into new ordinary shares in the Company.

 

· The conversion price of any part of an advance will be 90 per cent of the daily VWAP over the three trading days immediately prior to conversion and the Loan Notes shall be converted at 105 per cent of face value.

 

· In conjunction with the Initial Advance, the Investor will be issued with 52,447,552 three year warrants with an exercise price of 1.43 pence per ordinary share.

 

· If the Investor exercises any Warrants, the exercise price will in the first instance be set off against any Loan amounts outstanding.

 

· The net proceeds of the Initial Advance will be used by the Company to progress development of the Company's Kun-Manie nickel copper sulphide project.

 

 

Robin Young, CEO of Amur Minerals Corporation, commented:

 

"We are pleased to have completed this financing with Plena Global Opportunities LLC. This staged funding will allow us to continue toward the completion of the Permanent Conditions TEO due for completion in Q4 this year.

 

"Following the appointment of Adam Habib as advisor to the board last month, the completion of the TEO is key to securing strategic investors, infrastructure funds and prepay finance via offtake partners.

 

"The next and most significant deliverable for inclusion in the TEO is Gipronickel's determination of the ability of the Company to generate separate saleable concentrates for copper and for nickel. As noted in earlier RNS information, as much as US$750 million could be generated in payable copper revenue substantially enhancing project economics and allowing for the Company to identify additional off-takers for the Kun-Manie generated intermediate products."

 

Adam Habib, Advisor to the Board of Amur Minerals Corporation, commented:

 

"It is essential that the TEO (Russia BFS) be completed as it is one of the key requirements before Amur can engage with off-takers. This funding enables this key hurdle to be achieved thereby allowing the Company to move onto the next set of deliverables and engage confidently with the nickel and copper market participants."

 

 

 

 

The Initial Advance

 

Under the terms of the Loan the Company will draw down the initial advance of £0.5 million with a maturity date of 11 June 2020. In addition to this, the Company will issue the Investor with 52,447,552 warrants with an exercise price of 1.43p.

 

 

Use of Funds

 

The net proceeds of the Initial Advance will be used by the Company to progress development of the Company's Kun-Manie nickel copper sulphide project including:

 

1. completion of the test work related to the derivation of individual copper and nickel concentrates;

2. advancement of an optimised production schedule;

3. follow-on update of the current economic model including all newly acquired technical data and cost information and additional metallurgical test work results; and

4. general and administrative requirements.

 

The net proceeds from the second and final advances will be used by the Company to:

 

1. continue the compilation of the TEO through to completion;

2. on-going engagement with the nickel and copper market participants;

3. general and administrative requirements.

 

Overview of the Loan and Warrant Agreements

 

The Investors will lend up to £1.5 million cash to the Company through the Loan consisting of three separate advances, with the Initial Advance being drawn down and funds expected to be received by 13 March 2020.

 

The subsequent advances of £0.5 million would be made available three months after the Initial Advance, with the final advance available six months after the Initial Advance. Both the subsequent and final advances will be made by mutual consent.

 

Each advance is repayable three months after the advance is made. However, if any of the relevant tranches of Loan Notes are not repaid at that date, the term of the Loan Notes shall automatically be extended by a further period of 12 months, to the date falling 15 months from the date of issue of the relevant Loan Notes. If the Company elects not to repay the advance by the applicable repayment date the Investor can elect to convert that outstanding advance at any time into new ordinary shares in the Company. The conversion price of any part of an advance will be 90 per cent of the daily VWAP over the three trading days immediately prior to conversion and the Loan Notes shall be converted at 105 per cent of face value.

 

When Loan Notes are redeemed the Company shall pay the noteholder in cash an amount equal to 105 per cent of the principal amount of the Loan Notes plus interest equal to 10 per cent of the principal amount being so redeemed.

 

At each advance, warrants for a number of new ordinary shares with a value equal to £750,000 will be issued with a price per Ordinary Share equal to the mid-market price at the close of business on business day immediately preceding the date of issue. The Warrants will be exercisable for a period of three years.

 

In the event the Investor exercises the Warrants, the funds from the exercise will first be set off against any Loan amounts outstanding. Should there be no Loan amounts outstanding, the Company will receive the funds directly from the warrant exercise as per usual.

 

The Company, at its option, shall have the right to redeem the outstanding amount of an advance, in full or in part at any time. Amur shall pay an amount equal to 115 per cent of the principal portion of the amount being redeemed.

 

 

 

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

Enquiries:

Company

Amur Minerals Corp.

Nomad and Broker

S.P. Angel Corporate Finance LLP

Public Relations

Blytheweigh

Robin Young CEO

Richard Morrison

Soltan Tagiev

Megan Ray

Tim Blythe

+7 (4212) 75 56 15

+44 (0) 20 3470 0470

+44 (0) 20 7138 3204

 

For additional information, visit the Company's website, www.amurminerals.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBLLFFBXLZBBQ
Date   Source Headline
25th Jan 202211:21 amRNSPress Speculation & Share Price Movement
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20211:44 pmRNSAnnual General Meeting Results
24th Nov 20217:00 amRNSShareholder Q&A
12th Nov 20217:00 amRNSNotice of Annual General Meeting
30th Sep 20217:00 amRNSInterim Results 2021
24th Aug 20214:35 pmRNSPrice Monitoring Extension
20th Aug 20218:58 amRNSKun-Manie TEO Submitted For Review
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
5th Jul 20217:00 amRNSSale of Subsidiary
30th Jun 20217:00 amRNSAUDITED FINAL RESULTS ENDED 31 DECEMBER 2020
30th Jun 20217:00 amRNSKun-Manie JORC Resource Update
21st Apr 20214:41 pmRNSSecond Price Monitoring Extn
21st Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 20218:54 amRNSQ1 2021 NRR Convertible Loan Note Payment
12th Mar 20214:40 pmRNSSecond Price Monitoring Extn
12th Mar 20214:35 pmRNSPrice Monitoring Extension
16th Feb 20217:00 amRNSKun-Manie Production Licence Amendments & Update
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:36 pmRNSPrice Monitoring Extension
14th Jan 20217:40 amRNSQ4 2020 NRR Convertible Loan Note Payment Receipt
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSCFO change
10th Dec 202011:54 amRNSAnnual General Meeting Results
25th Nov 20203:01 pmRNSKun-Manie TEO Progress Report
13th Nov 20207:00 amRNSNotice of Annual General Meeting
11th Nov 20204:41 pmRNSSecond Price Monitoring Extn
11th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20204:35 pmRNSPrice Monitoring Extension
2nd Nov 20206:08 pmRNSPDMR Dealing
30th Oct 202010:39 amRNSNRR Update
27th Oct 20209:43 amRNSPDMR Dealing
27th Oct 20207:00 amRNSNRR Update
15th Oct 202011:03 amRNSIssue of Equity - Replacement
15th Oct 202010:22 amRNSIssue of Equity
14th Oct 20209:26 amRNSDirector Change
12th Oct 20204:36 pmRNSPrice Monitoring Extension
7th Oct 20207:00 amRNSNRR Update
30th Sep 20207:00 amRNSInterim Results 2020
3rd Sep 20207:00 amRNSExercise of Warrants and Issue of Equity
2nd Sep 20207:00 amRNSExecutive Addition to the Board of Directors
25th Aug 20208:50 amRNSEquity Placing to raise £6.1 million
19th Aug 20204:40 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.